87,058 Shares in Danaher Co. (NYSE:DHR) Acquired by Oddo BHF Asset Management Sas

Oddo BHF Asset Management Sas purchased a new stake in Danaher Co. (NYSE:DHR - Free Report) in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 87,058 shares of the conglomerate's stock, valued at approximately $24,204,000. Danaher comprises approximately 1.2% of Oddo BHF Asset Management Sas' portfolio, making the stock its 18th biggest holding.

A number of other hedge funds and other institutional investors also recently modified their holdings of DHR. Fort Pitt Capital Group LLC grew its holdings in Danaher by 3.2% during the third quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate's stock worth $66,194,000 after purchasing an additional 7,421 shares during the period. Good Life Advisors LLC bought a new position in shares of Danaher during the 3rd quarter worth approximately $217,000. Oak Thistle LLC acquired a new position in shares of Danaher during the 2nd quarter worth approximately $363,000. Harvest Portfolios Group Inc. raised its stake in Danaher by 1.2% in the 3rd quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate's stock valued at $56,233,000 after acquiring an additional 2,465 shares during the period. Finally, Stifel Financial Corp lifted its holdings in Danaher by 1.3% during the 3rd quarter. Stifel Financial Corp now owns 847,348 shares of the conglomerate's stock valued at $235,583,000 after purchasing an additional 11,216 shares during the last quarter. Institutional investors own 79.05% of the company's stock.

Danaher Price Performance

Shares of DHR stock traded up $0.49 on Friday, reaching $234.99. The company had a trading volume of 2,417,903 shares, compared to its average volume of 2,784,963. The stock has a market capitalization of $169.73 billion, a PE ratio of 44.75, a price-to-earnings-growth ratio of 4.33 and a beta of 0.83. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. The business's 50-day moving average is $247.62 and its 200 day moving average is $257.62. Danaher Co. has a one year low of $222.53 and a one year high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The company had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.59 billion. During the same period in the prior year, the business earned $2.02 earnings per share. The company's revenue for the quarter was up 3.1% compared to the same quarter last year. Equities research analysts forecast that Danaher Co. will post 7.5 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Friday, December 27th will be paid a $0.27 dividend. This represents a $1.08 annualized dividend and a dividend yield of 0.46%. The ex-dividend date is Friday, December 27th. Danaher's dividend payout ratio is currently 20.61%.

Analysts Set New Price Targets

DHR has been the topic of several research analyst reports. Evercore ISI increased their price objective on shares of Danaher from $275.00 to $278.00 and gave the company an "outperform" rating in a research report on Tuesday, October 1st. KeyCorp increased their price target on shares of Danaher from $290.00 to $310.00 and gave the company an "overweight" rating in a report on Wednesday, October 23rd. StockNews.com downgraded Danaher from a "buy" rating to a "hold" rating in a research report on Thursday, December 5th. Robert W. Baird dropped their price target on Danaher from $278.00 to $277.00 and set an "outperform" rating for the company in a report on Wednesday, October 23rd. Finally, TD Cowen upped their price objective on Danaher from $310.00 to $315.00 and gave the company a "buy" rating in a report on Wednesday, October 23rd. Five analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $287.95.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.